The patently obvious need to protect COVID-19 vaccine intellectual property
Study highlights dire need for improved access to emergency care
8 November 2021Advanced photon source helps Pfizer create COVID-19 antiviral treatment
8 November 2021The patently obvious need to protect COVID-19 vaccine intellectual property
Kelli Larson of the School of Business, Law and Entrepreneurship at Swinburne University of Technology in Hawthorn, Victoria, Australia, discusses the role of patents in the context of COVID-19 vaccines in the International Journal of Intellectual Property Management.
